Cargando…
Plasma Angiotensin Converting Enzyme 2 (ACE2) Activity in Healthy Controls and Patients with Cardiovascular Risk Factors and/or Disease
Angiotensin converting enzyme 2 (ACE2) is an endogenous negative regulator of the renin-angiotensin system, a key factor in the development of cardiovascular disease (CVD). ACE2 is also used by SARS-CoV-2 for host cell entry. Given that COVID-19 is associated with hypercoagulability, it is timely to...
Autores principales: | Lim, Hui Yin, Patel, Sheila K., Huang, Ping, Tacey, Mark, Choy, Kay Weng, Wang, Julie, Donnan, Geoffrey, Nandurkar, Harshal H., Ho, Prahlad, Burrell, Louise M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501250/ https://www.ncbi.nlm.nih.gov/pubmed/36143280 http://dx.doi.org/10.3390/jpm12091495 |
Ejemplares similares
-
The Need for Individualized Risk Assessment in Cardiovascular Disease
por: Lim, Hui Yin, et al.
Publicado: (2022) -
Global coagulation assays in patients with diabetes mellitus
por: Lim, Hui Yin, et al.
Publicado: (2021) -
Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1–7) levels in experimental biliary fibrosis()
por: Herath, Chandana B., et al.
Publicado: (2007) -
Manipulating angiotensin metabolism with angiotensin converting enzyme 2 (ACE2) in heart failure
por: Patel, Vaibhav B., et al.
Publicado: (2012) -
Hypertension and renin-angiotensin system blockers are not associated with expression of angiotensin-converting enzyme 2 (ACE2) in the kidney
por: Jiang, Xiao, et al.
Publicado: (2020)